Eli Lilly and Co (NYSE:LLY)
| 370.19 Delayed Data As of 3:22pm ET |  -1.78 / -0.48%Today’s Change | 231.87 Today|||52-Week Range 375.25 | +34.02% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 371.97 |
| Today’s open | 373.26 |
| Day’s range | 367.00 - 373.26 |
| Volume | 1,404,442 |
| Average volume (3 months) | 2,940,014 |
| Market cap | $356.1B |
Data as of 3:22pm ET, 12/08/2022
Growth & Valuation
| Earnings growth (last year) | -9.81% |
| Earnings growth (this year) | -4.42% |
| Earnings growth (next 5 years) | +21.35% |
| Revenue growth (last year) | +15.40% |
| P/E ratio | 55.7 |
| Price/Sales | 8.89 |
| Price/Book | 39.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +0.17 | +0.10% |
| PFEPfizer | +1.33 | +2.65% |
| MRKMerck | +0.69 | +0.63% |
| JNJJohnson & Johnson | -0.11 | -0.06% |
Data as of 3:22pm ET, 12/08/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $1.93 |
| Annual revenue (last year) | $28.3B |
| Annual profit (last year) | $5.6B |
| Net profit margin | 19.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
